Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 2Phase NA 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 10Multiple Myeloma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Hodgkin Disease 5Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma 4Hematologic Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Recurrence 3Primary Myelofibrosis 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Prolymphocytic 2Leukemia, Plasma Cell 2Burkitt Lymphoma 2Thalassemia 1Skin Neoplasms 1Polycythemia Vera 1Peritoneal Tumor 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myeloid Hematological Malignancies 1Mesothelin-positive Advanced Malignant Solid Tumors 1

Interventions

fludarabine 1Voriconazole 1Thalidomide 1Semen Analysis 1Remote Patient Monitoring 1Physical Examination 1Interviews as Topic 1Health Information Exchange 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Fluconazole 1Exercise 1Dexamethasone 1Cyclophosphamide 1Complementary Therapies 1Cell- and Tissue-Based Therapy 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Bismuth 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematologic Diseases × fludarabine × Clear all
NCT00582894 2011-04-22

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

University of Oklahoma

Phase NA Completed
17 enrolled 9 charts
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡